Industry News: Waters Corporation to Exhibit at AACR 2016

11 Apr 2016


Focused on Biomarker Discovery, Translation and Clinical Research, Waters offers technologies and solutions to accelerate the discovery and translation of cancer biomarkers. Liquid chromatography and mass spectrometry (LC-MS) is now recognized by leading research professionals as an optimal analytical technique for biomarker research methods.  

Waters Corporation, in booth #2512, will highlight their “Meet the Expert” program on April 18-19 where visitors can talk one to one with 3 experts.  Details on the scheduled times for these experts can be found on www.waters.com/aacr.

  • Molecular Profiling - Dr.  Arash Zarrine-Afsar, Ph.D. from Techna Institute for the Advancement of Technology for Health, part of the University Health Network at the University of Toronto will be talking with visitors about Rapid Characterization of Cancer by Molecular Profiling
  • Biomarker Discovery and Quantification - Dr. Maureen Kane, the Executive Director of the University of Maryland School of Pharmacy Mass Spectrometry Center, and also a Waters Centers of Innovation partner, will be discussing strategies and technologies for untargeted and targeted assays in biomarker discovery and quantification.
  • Characterizing ADC’s - Dr. John Gebler, a Director of Biopharma Business Development, at Waters Corporation will be meeting with visitors to discuss solving the challenges of characterizing antibody drug conjugates (ADCs).


Waters provides a diverse portfolio of analytical systems for the identification and measurement of a variety of analytes.